Adverum Bio Ownership 2024 | Who Owns Adverum Bio Now?


OverviewForecastFinancialsChart

Institutional Ownership

15.26%

Insider Ownership

11.67%

Retail Ownership

73.07%

Institutional Holders

2.00

Adverum Bio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TCG CROSSOVER MANAGEMENT, LLC12.19%1.44%2,008,340--13,777,212Jun 30, 2024
VERSANT VENTURE MANAGEMENT, LLC3.08%4.50%506,821-1-0.00%3,476,792Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,069,244-100.00%-Jun 30, 2024

Adverum Bio's largest institutional shareholder is TCG CROSSOVER MANAGEMENT, LLC, holding 12.19% of the company's total share outstanding, currently valued at $13.78M. The top 10 institutional shareholders own together 15.26% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VERSANT VENTURE MANAGEMENT, LLC3.08%4.50%506,821-1-0.00%3,476,792Jun 30, 2024
TCG CROSSOVER MANAGEMENT, LLC12.19%1.44%2,008,340--13,777,212Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,069,244-100.00%-Jun 30, 2024

The largest Adverum Bio shareholder by % of total assets is VERSANT VENTURE MANAGEMENT, LLC. The company owns 506.82K shares of Adverum Bio (ADVM), representing 4.50% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TCG CROSSOVER MANAGEMENT, LLC12.19%1.44%2,008,340--13,777,212Jun 30, 2024
VERSANT VENTURE MANAGEMENT, LLC3.08%4.50%506,821-1-0.00%3,476,792Jun 30, 2024
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,069,244-100.00%-Jun 30, 2024

As of Jun 30 2024, Adverum Bio's largest institutional buyer is TCG CROSSOVER MANAGEMENT, LLC. The company purchased 0.00 stocks of ADVM, valued at $13.78M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,069,244-100.00%-Jun 30, 2024
VERSANT VENTURE MANAGEMENT, LLC3.08%4.50%506,821-1-0.00%3,476,792Jun 30, 2024
TCG CROSSOVER MANAGEMENT, LLC12.19%1.44%2,008,340--13,777,212Jun 30, 2024

As of Jun 30 2024, Adverum Bio's biggest institutional seller is FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The company sold -1.07M shares of ADVM, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.----1,069,244-100.00%-Jun 30, 2024

Adverum Bio's largest sold out institutional shareholder by shares sold is FRAZIER LIFE SCIENCES MANAGEMENT, L.P., sold -1.07M shares, valued at -, as of undefined.

Adverum Bio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
HARTFORD HLS SERIES FUND II INC1.62%398,595--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.15%76,000--Mar 31, 2024
FRANKLIN STRATEGIC SERIES0.14%1,156,6561,156,656-Jan 31, 2024
T. Rowe Price Health Sciences Fund, Inc.0.11%367,524--Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.09%468,861--Mar 31, 2024
Federated Hermes MDT Series0.04%103,776--Jan 31, 2024
ETFis Series Trust I0.04%57,768--Jan 31, 2024
Fidelity Commonwealth Trust II0.03%173,968--Aug 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%14,257--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%136,226--Mar 31, 2024
BRIDGEWAY FUNDS INC0.02%50,000--Mar 28, 2024
NEW COVENANT FUNDS0.02%85,190--Dec 31, 2023
UBS FUNDS0.02%75,492--Mar 31, 2024
ALGER FUNDS0.02%14,618--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.01%46,742--Feb 29, 2024
BNY Mellon Strategic Funds, Inc.0.01%30,239--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.01%21,723--Mar 31, 2024
North Square Investments Trust0.01%120,753--Jan 31, 2024
VANGUARD INDEX FUNDS0.01%5,239,144--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%2,388--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.01%113,644--Mar 31, 2024
ALPS ETF Trust0.01%116,276--Feb 29, 2024
PRIMECAP Odyssey Funds0.01%75,000--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%546,840-5,324,652-90.69%Feb 29, 2024
JNL VARIABLE FUND LLC0.01%39,896--Mar 31, 2020
FIDELITY COVINGTON TRUST0.01%119,557-11-0.01%Feb 29, 2024
FORUM FUNDS II0.01%6,400--Jan 31, 2024
VANGUARD EXPLORER FUND0.01%70,057--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%862,73592,57212.02%Feb 29, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%303,742--Jan 31, 2024
Calvert Variable Products, Inc.0.00%7,403--Mar 31, 2024
NORTHWESTERN MUTUAL SERIES FUND INC0.00%239,611--Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%67,508--Mar 31, 2024
VICTORY PORTFOLIOS0.00%61,050--Mar 31, 2024
HARTFORD MUTUAL FUNDS II INC0.00%275,190--Jan 31, 2024
SunAmerica Specialty Series0.00%716--Apr 30, 2021
Voya VARIABLE PORTFOLIOS INC0.00%36,284--Mar 31, 2024
SSGA FUNDS0.00%495--Feb 29, 2024
VALIC Co II0.00%37,651--Feb 28, 2021
Virtus Investment Trust0.00%34,296--Mar 28, 2024
Principal Exchange-Traded Funds0.00%11,117--Mar 31, 2024
AMG FUNDS III0.00%4,600--Mar 28, 2024
SCHWAB CAPITAL TRUST0.00%36,413--Jan 31, 2024
VANGUARD WORLD FUND0.00%187,908--Feb 29, 2024
SCHWAB STRATEGIC TRUST0.00%404,151--Feb 29, 2024
Virtus Strategy Trust0.00%12,579--Mar 28, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%37,600--Mar 31, 2024
Global X Funds0.00%24,618--Jan 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%2,646--Mar 31, 2024
SA FUNDS INVESTMENT TRUST0.00%8,282--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%1,303--Mar 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%23,647--Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%57,695--Mar 31, 2024
MAINSTAY VP FUNDS TRUST0.00%50,600--Mar 31, 2024
THRIVENT SERIES FUND INC0.00%43,545--Mar 28, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%1,551--Mar 31, 2024
NORTHERN FUNDS0.00%52,063--Mar 28, 2024
OHIO NATIONAL FUND INC0.00%6,755--Mar 31, 2024
ADVISORS' INNER CIRCLE FUND0.00%6,519--Jan 31, 2024
GPS Funds I0.00%1,316--Mar 31, 2024
THRIVENT MUTUAL FUNDS0.00%20,278--Mar 28, 2024
FLEXSHARES TRUST0.00%16,849--Jan 31, 2024
Direxion Shares ETF Trust0.00%31,934--Jan 31, 2024
RYDEX SERIES FUNDS0.00%828--Dec 31, 2023
AdvisorShares Trust0.00%742--Mar 28, 2024
RUSSELL INVESTMENT CO0.00%51,540--Jan 31, 2024
MAINSTAY FUNDS TRUST0.00%35,100--Jan 31, 2024
ProFunds0.00%1,864--Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%620,853--Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%296,961--Feb 29, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%7,272--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%125,115--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%2,621--Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%13,058--Feb 29, 2024
RYDEX DYNAMIC FUNDS0.00%458--Dec 31, 2023
VALIC Co I0.00%32,200--Feb 29, 2024
PENN SERIES FUNDS INC0.00%2,600--Mar 28, 2024
NATIONWIDE MUTUAL FUNDS0.00%11,628--Jan 31, 2024
Guggenheim Active Allocation Fund0.00%517--Feb 29, 2024
Dimensional ETF Trust0.00%35,996--Jan 31, 2024
Pacer Funds Trust0.00%3,681--Jan 31, 2024
MASTER INVESTMENT PORTFOLIO0.00%6,809--Mar 31, 2024
PGIM ETF TRUST0.00%4,714--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%83--Dec 31, 2023
TIAA-CREF FUNDS0.00%214,312--Mar 31, 2024
RUSSELL INVESTMENT FUNDS0.00%7,648--Mar 31, 2024
Blackstone Alternative Investment Funds0.00%7,000--Mar 31, 2024
Goldman Sachs ETF Trust0.00%4,919--Feb 29, 2024
HC CAPITAL TRUST0.00%1,601--Mar 31, 2024
ADVANCED SERIES TRUST0.00%137,300--Mar 28, 2024
BLACKROCK FUNDS0.00%285,324--Mar 28, 2024
USAA MUTUAL FUNDS TRUST0.00%9,656--Jan 31, 2024
PROSHARES TRUST0.00%8,354--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%3,265--Feb 29, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%29,021--Jan 31, 2024
Brighthouse Funds Trust II0.00%23,892--Mar 31, 2024
ETF Series Solutions0.00%570--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%9,579--Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS0.00%100--Mar 31, 2024
ALLSPRING MASTER TRUST0.00%1,183--Feb 29, 2024

Adverum Bio's largest mutual fund holder by % of total assets is "HARTFORD HLS SERIES FUND II INC", owning 398.60K shares, compromising 1.62% of its total assets.

Adverum Bio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 242-33.33%
31 Mar, 243-95.31%
31 Dec, 23641.59%
30 Sep, 23636.78%
30 Jun, 23593.51%
31 Mar, 2357-12.31%
31 Dec, 2265-16.67%
30 Sep, 22784.00%
30 Jun, 2275-19.35%
31 Mar, 2293-11.43%
31 Dec, 21105-9.48%
30 Sep, 21116-7.94%
30 Jun, 21126-8.03%
31 Mar, 21137-14.91%
31 Dec, 20161-3.59%
30 Sep, 2016711.33%
30 Jun, 2015011.11%
31 Mar, 201357.14%
31 Dec, 1912610.53%
30 Sep, 1911416.33%
30 Jun, 199818.07%
31 Mar, 1983-3.49%
31 Dec, 1886-18.87%
30 Sep, 18106-
30 Jun, 181064.95%
31 Mar, 1810148.53%
31 Dec, 176817.24%
30 Sep, 1758-6.45%
30 Jun, 1762-16.22%
31 Mar, 1774-11.90%
31 Dec, 16849.09%
30 Sep, 1677-1.28%
30 Jun, 16782500.00%
31 Mar, 163-

As of 30 Jun 24, 2 institutions are holding Adverum Bio's shares, representing a decrease of -33.33% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 242,515,161-29.83%
31 Mar, 243,584,406-94.42%
31 Dec, 2364,234,984-1.62%
30 Sep, 2365,292,881-0.55%
30 Jun, 2365,656,2384.68%
31 Mar, 2362,722,7919.46%
31 Dec, 2257,303,200-2.08%
30 Sep, 2258,522,2630.53%
30 Jun, 2258,214,076-7.95%
31 Mar, 2263,241,519-4.15%
31 Dec, 2165,979,917-5.73%
30 Sep, 2169,993,314-11.60%
30 Jun, 2179,177,065-16.79%
31 Mar, 2195,158,8330.90%
31 Dec, 2094,312,069-0.85%
30 Sep, 2095,120,46917.66%
30 Jun, 2080,844,0501.02%
31 Mar, 2080,027,15633.05%
31 Dec, 1960,146,73122.71%
30 Sep, 1949,013,7865.71%
30 Jun, 1946,364,22616.73%
31 Mar, 1939,718,6343.33%
31 Dec, 1838,438,41511.26%
30 Sep, 1834,548,216-5.77%
30 Jun, 1836,662,0765.96%
31 Mar, 1834,598,32479.96%
31 Dec, 1719,225,60441.64%
30 Sep, 1713,573,2324.29%
30 Jun, 1713,014,293-3.76%
31 Mar, 1713,522,837-10.43%
31 Dec, 1615,097,265-1.13%
30 Sep, 1615,269,686-3.19%
30 Jun, 1615,772,3526868.40%
31 Mar, 16226,341-

Adverum Bio (ADVM) has 2.52M shares outstanding as of 30 Jun 24, down -29.83% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2415.26%1.22%
31 Mar, 2435.41%0.88%
31 Dec, 2363.60%1.51%
30 Sep, 2364.80%1.51%
30 Jun, 2365.46%1.67%
31 Mar, 2362.53%1.88%
31 Dec, 2257.74%1.67%
30 Sep, 2258.83%1.70%
30 Jun, 2258.80%1.43%
31 Mar, 2264.14%1.42%
31 Dec, 2167.30%1.32%
30 Sep, 2171.33%1.09%
30 Jun, 2180.78%0.85%
31 Mar, 2197.35%1.05%
31 Dec, 2096.48%0.84%
30 Sep, 20107.04%1.05%
30 Jun, 20100.77%0.86%
31 Mar, 20108.44%1.23%
31 Dec, 1993.83%1.62%
30 Sep, 1976.01%1.44%
30 Jun, 1972.74%1.84%
31 Mar, 1962.92%1.60%
31 Dec, 1862.63%2.05%
30 Sep, 1855.32%1.60%
30 Jun, 1858.79%1.62%
31 Mar, 1860.25%5.37%
31 Dec, 1733.48%3.42%
30 Sep, 1731.29%3.42%
30 Jun, 1730.26%2.94%
31 Mar, 1732.09%1.85%
31 Dec, 1641.65%3.06%
30 Sep, 1636.87%1.82%
30 Jun, 1645.01%6449.33%
31 Mar, 160.84%-

As of 30 Jun 24, Adverum Bio is held by 15.26% institutional shareholders, representing a 1.22% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24--100.00%
31 Mar, 242-90.91%
31 Dec, 2322-15.38%
30 Sep, 232623.81%
30 Jun, 232116.67%
31 Mar, 2318-28.00%
31 Dec, 2225-7.41%
30 Sep, 22278.00%
30 Jun, 222513.64%
31 Mar, 2222-40.54%
31 Dec, 2137-27.45%
30 Sep, 2151-26.09%
30 Jun, 216927.78%
31 Mar, 2154-30.77%
31 Dec, 2078-22.00%
30 Sep, 2010011.11%
30 Jun, 209011.11%
31 Mar, 208124.62%
31 Dec, 1965-2.99%
30 Sep, 196721.82%
30 Jun, 195544.74%
31 Mar, 1938-2.56%
31 Dec, 1839-29.09%
30 Sep, 1855-16.67%
30 Jun, 1866-5.71%
31 Mar, 187066.67%
31 Dec, 174268.00%
30 Sep, 1725-
30 Jun, 1725-30.56%
31 Mar, 1736-7.69%
31 Dec, 163914.71%
30 Sep, 1634-55.26%
30 Jun, 16762433.33%
31 Mar, 163-

- institutional shareholders have increased their position in ADVM stock as of 30 Jun 24 compared to 2 in the previous quarter (a -100.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 241-
31 Mar, 241-93.75%
31 Dec, 2316-20.00%
30 Sep, 2320-13.04%
30 Jun, 232321.05%
31 Mar, 2319-17.39%
31 Dec, 2223-23.33%
30 Sep, 223011.11%
30 Jun, 2227-38.64%
31 Mar, 22442.33%
31 Dec, 214319.44%
30 Sep, 213620.00%
30 Jun, 2130-41.18%
31 Mar, 21514.08%
31 Dec, 204925.64%
30 Sep, 20392.63%
30 Jun, 20388.57%
31 Mar, 2035-7.89%
31 Dec, 1938100.00%
30 Sep, 1919-20.83%
30 Jun, 19249.09%
31 Mar, 1922-12.00%
31 Dec, 18254.17%
30 Sep, 182414.29%
30 Jun, 182150.00%
31 Mar, 181440.00%
31 Dec, 1710-33.33%
30 Sep, 1715-21.05%
30 Jun, 1719-9.52%
31 Mar, 1721-12.50%
31 Dec, 1624-
30 Sep, 1624-
30 Jun, 16--
31 Mar, 16--

1 institutional shareholders have reduced their position in ADVM stock as of 30 Jun 24 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 242-33.33%2,515,161-29.83%15.26%1.22%--100.00%1-
31 Mar, 243-95.31%3,584,406-94.42%35.41%0.88%2-90.91%1-93.75%
31 Dec, 23641.59%64,234,984-1.62%63.60%1.51%22-15.38%16-20.00%
30 Sep, 23636.78%65,292,881-0.55%64.80%1.51%2623.81%20-13.04%
30 Jun, 23593.51%65,656,2384.68%65.46%1.67%2116.67%2321.05%
31 Mar, 2357-12.31%62,722,7919.46%62.53%1.88%18-28.00%19-17.39%
31 Dec, 2265-16.67%57,303,200-2.08%57.74%1.67%25-7.41%23-23.33%
30 Sep, 22784.00%58,522,2630.53%58.83%1.70%278.00%3011.11%
30 Jun, 2275-19.35%58,214,076-7.95%58.80%1.43%2513.64%27-38.64%
31 Mar, 2293-11.43%63,241,519-4.15%64.14%1.42%22-40.54%442.33%
31 Dec, 21105-9.48%65,979,917-5.73%67.30%1.32%37-27.45%4319.44%
30 Sep, 21116-7.94%69,993,314-11.60%71.33%1.09%51-26.09%3620.00%
30 Jun, 21126-8.03%79,177,065-16.79%80.78%0.85%6927.78%30-41.18%
31 Mar, 21137-14.91%95,158,8330.90%97.35%1.05%54-30.77%514.08%
31 Dec, 20161-3.59%94,312,069-0.85%96.48%0.84%78-22.00%4925.64%
30 Sep, 2016711.33%95,120,46917.66%107.04%1.05%10011.11%392.63%
30 Jun, 2015011.11%80,844,0501.02%100.77%0.86%9011.11%388.57%
31 Mar, 201357.14%80,027,15633.05%108.44%1.23%8124.62%35-7.89%
31 Dec, 1912610.53%60,146,73122.71%93.83%1.62%65-2.99%38100.00%
30 Sep, 1911416.33%49,013,7865.71%76.01%1.44%6721.82%19-20.83%
30 Jun, 199818.07%46,364,22616.73%72.74%1.84%5544.74%249.09%
31 Mar, 1983-3.49%39,718,6343.33%62.92%1.60%38-2.56%22-12.00%
31 Dec, 1886-18.87%38,438,41511.26%62.63%2.05%39-29.09%254.17%
30 Sep, 18106-34,548,216-5.77%55.32%1.60%55-16.67%2414.29%
30 Jun, 181064.95%36,662,0765.96%58.79%1.62%66-5.71%2150.00%
31 Mar, 1810148.53%34,598,32479.96%60.25%5.37%7066.67%1440.00%
31 Dec, 176817.24%19,225,60441.64%33.48%3.42%4268.00%10-33.33%
30 Sep, 1758-6.45%13,573,2324.29%31.29%3.42%25-15-21.05%
30 Jun, 1762-16.22%13,014,293-3.76%30.26%2.94%25-30.56%19-9.52%
31 Mar, 1774-11.90%13,522,837-10.43%32.09%1.85%36-7.69%21-12.50%
31 Dec, 16849.09%15,097,265-1.13%41.65%3.06%3914.71%24-
30 Sep, 1677-1.28%15,269,686-3.19%36.87%1.82%34-55.26%24-
30 Jun, 16782500.00%15,772,3526868.40%45.01%6449.33%762433.33%--
31 Mar, 163-226,341-0.84%-3---

Adverum Bio Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 31, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy85,800$7.15$613.47K2,268,064
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy80,718$9.11$735.74K2,182,264
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy135,546$7.75$1.05M2,101,546

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 31, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy85,800$7.15$613.47K2,268,064
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy80,718$9.11$735.74K2,182,264
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy135,546$7.75$1.05M2,101,546

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2024Leonard Braden Michael10 percent owner-Sell---104,800

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 06, 2024Ozden Rabia Gursesofficer Chief Medical OfficerA-AwardBuy44,010$7.15$314.67K44,010
Aug 06, 2024Rubinstein Linda Mofficer CHIEF FINANCIAL OFFICERA-AwardBuy62,083$7.15$443.89K62,083
Aug 06, 2024Seyedkazemi Setarehofficer CHIEF DEVELOPMENT OFFICERA-AwardBuy43,458$7.15$310.72K43,458
Aug 06, 2024Soparkar Peterofficer CHIEF OPERATING OFFICERA-AwardBuy64,394$7.15$460.42K64,394
Aug 06, 2024Fischer Laurentdirector, officer CEO, PRESIDENT AND DIRECTORA-AwardBuy200,000$7.15$1.43M200,000
Jul 31, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy85,800$7.15$613.47K2,268,064
Jul 18, 2024Leonard Braden Michael10 percent owner-Buy---2,103,176
Jul 18, 2024Leonard Braden Michael10 percent owner-Sell---104,800
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy80,718$9.11$735.74K2,182,264
Jul 18, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy135,546$7.75$1.05M2,101,546
Jun 20, 2024Ozden Rabia Gursesofficer Chief Medical OfficerA-AwardBuy85,000$7.32$622.20K85,000
Jun 20, 2024Nicholson, C. Daviddirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Hong Soodirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Lupher, Jr. Mark L.director-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Svoronos Dawndirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Tuckson Reed Vaughndirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Whitcup Scott Mdirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Scopa James Pauldirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Machado Patrickdirector-A-AwardBuy10,520$7.32$77.01K10,520
Jun 20, 2024Machado Patrickdirector-A-AwardBuy3,300$7.32$24.16K3,300

The last insider sell of Adverum Bio's stock was made by Leonard Braden Michael on Jul 18 2024, selling - shares at - per share (valued at -). The last insider buy of ADVM was made by Leonard Braden Michael on Jul 31 2024, buying 85,800 shares at $7.15 per share (worth $613.47K).

Adverum Bio Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202431300.00%
Q2 2024116183.33%
Q1 20246--
Q4 202341400.00%
Q3 20231250.00%
Q2 202310--
Q1 202353166.67%
Q4 2022-1-
Q3 202242200.00%
Q2 2022177242.86%
Q1 202294225.00%
Q4 202142200.00%
Q3 202175140.00%
Q2 202194225.00%
Q1 2021113366.67%
Q4 202022100.00%
Q3 202032150.00%
Q2 2020232979.31%
Q1 2020171894.44%
Q4 20191333.33%

3 total buy trades, and 1 total sell trades (buy/sell ratio of 3.00%) were made by Adverum Bio's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20243--
Q2 2024---
Q1 20242--
Q4 2023---
Q3 2023-2-
Q2 20231--
Q1 2023-3-
Q4 2022---
Q3 2022-2-
Q2 20227--
Q1 2022---
Q4 202131300.00%
Q3 2021-1-
Q2 2021---
Q1 202152250.00%
Q4 2020---
Q3 202021200.00%
Q2 2020-16-
Q1 20201520.00%
Q4 2019-2-

As of Q3 2024, Insider owners conducted 3 open market buy trades and 0 open market sell trades of Adverum Bio's stocks.

Adverum Bio Peer Ownership


TickerCompany
MREOMereo BioPharma Group plc
MGTXMeiraGTx Holdings plc
STOKStoke Therapeutics, Inc.
RCKTRocket Pharmaceuticals, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
ONCTOncternal Therapeutics, Inc.
ABSIAbsci Corporation
BCELAtreca, Inc.
GLMDGalmed Pharmaceuticals Ltd.
PASGPassage Bio, Inc.
ANTXAN2 Therapeutics, Inc.
KODKodiak Sciences Inc.
AFMDAffimed N.V.
RZLTRezolute, Inc.
RYTMRhythm Pharmaceuticals, Inc.
SLDBSolid Biosciences Inc.
ADAGAdagene Inc.
KZRKezar Life Sciences, Inc.
FIXXQ32 Bio Inc.
QUREuniQure N.V.

ADVM Ownership FAQ


Adverum Bio is owned by institutional shareholders (15.26%), insiders (11.67%), and public (73.07%). The largest institutional shareholder of Adverum Bio is TCG CROSSOVER MANAGEMENT, LLC (12.19% of total shares) and the top mutual fund owner is HARTFORD HLS SERIES FUND II INC (1.62% of total shares).

Adverum Bio's major institutional shareholders are TCG CROSSOVER MANAGEMENT, LLC, VERSANT VENTURE MANAGEMENT, LLC, and FRAZIER LIFE SCIENCES MANAGEMENT, L.P.. The top five shareholders own together 15.26% of the company's share outstanding.

As of Jun 2024, there are 2 institutional shareholders of Adverum Bio.

TCG CROSSOVER MANAGEMENT, LLC owns 2.01M shares of Adverum Bio, representing 12.19% of the company's total shares outstanding, valued at $13.78M (as of Jun 2024).

As of Jun 2024, VERSANT VENTURE MANAGEMENT, LLC holds 506.82K shares of Adverum Bio (ADVM), compromising 3.08% of the company, valued at $3.48M.

FRAZIER LIFE SCIENCES MANAGEMENT, L.P is the third largest holder of Adverum Bio. The company owns 0 of the company's shares outstanding (worth $0).